| |
| |
|
| Insider
Information: |
Bradsher Neal C |
| Relationship: |
10% Owner |
| City: |
Union City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
129,185 |
|
|
Indirect Shares
|
57,363,752 |
|
|
| Direct
Value |
$1,186,888 |
|
|
|
Indirect Value
|
$499,113,789 |
|
|
| Total
Shares |
57,492,937 |
|
|
| Total
Value |
$500,300,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
60
|
50
|
|
Stock
price went up :
|
44
|
16
|
| Stock
price went down : |
16
|
34
|
| |
|
|
|
Gain/Loss Ratio : |
2.8
|
2.8
|
| Percentage
Gain/Loss : |
 10.9%
|
 -929.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-01-26 |
4 |
S |
$102.33 |
$35,508,510 |
D/D |
(347,000) |
10,342,905 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-05-28 |
4 |
S |
$147.43 |
$32,094,479 |
D/D |
(217,693) |
9,060,921 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-01-28 |
4 |
S |
$105.83 |
$29,441,589 |
D/D |
(278,197) |
9,900,022 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-02-08 |
4 |
S |
$122.28 |
$17,710,791 |
D/D |
(144,838) |
9,646,623 |
0 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2014-04-07 |
4 |
AS |
$83.96 |
$17,212,087 |
D/D |
(205,000) |
2,046,660 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-01-27 |
4 |
S |
$103.99 |
$17,125,697 |
D/D |
(164,686) |
10,178,219 |
0 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2014-02-18 |
4 |
AS |
$73.68 |
$15,361,926 |
D/D |
(208,500) |
2,433,160 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2014-10-08 |
4 |
A |
$3.12 |
$12,606,432 |
D/D |
4,040,523 |
17,832,785 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2013-11-12 |
4 |
S |
$62.28 |
$12,197,243 |
D/D |
(195,844) |
2,970,694 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2013-11-13 |
4 |
S |
$62.56 |
$10,886,801 |
D/D |
(174,034) |
2,796,660 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-17 |
4 |
S |
$150.31 |
$9,604,208 |
D/D |
(63,896) |
8,905,918 |
0 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2013-11-11 |
4 |
S |
$62.25 |
$8,099,795 |
D/D |
(130,122) |
3,166,538 |
0 |
- |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2023-04-03 |
4 |
B |
$0.30 |
$8,093,898 |
D/D |
26,827,638 |
50,181,335 |
2.45 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-02-09 |
4 |
S |
$124.09 |
$8,075,901 |
D/D |
(65,081) |
9,581,542 |
0 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2015-09-14 |
4 |
A |
$3.29 |
$8,000,000 |
D/D |
2,431,611 |
20,264,396 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-04-23 |
4 |
S |
$133.51 |
$7,190,048 |
D/D |
(53,854) |
9,369,568 |
0 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2014-02-20 |
4 |
AS |
$77.73 |
$7,104,851 |
D/D |
(91,400) |
2,335,260 |
0 |
- |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2024-04-11 |
4 |
B |
$2.92 |
$7,057,688 |
D/D |
2,420,000 |
4,929,066 |
2.45 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2024-02-06 |
4 |
B |
$1.04 |
$7,000,001 |
D/D |
6,730,770 |
41,666,255 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2017-10-13 |
4 |
B |
$2.60 |
$6,999,998 |
D/D |
2,692,307 |
29,971,561 |
3.92 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-05-27 |
4 |
S |
$143.42 |
$6,822,633 |
D/D |
(47,571) |
9,278,614 |
0 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2013-06-13 |
4 |
S |
$45.24 |
$6,785,430 |
D/D |
(150,000) |
3,428,660 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2016-06-21 |
4 |
B |
$2.39 |
$6,531,000 |
D/D |
2,732,636 |
24,897,032 |
3.92 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2023-09-21 |
4 |
B |
$39.62 |
$6,133,467 |
D/D |
154,814 |
9,264,427 |
2.45 |
% |
|
| QCOR |
Questcor Pharmaceuticals ... |
Director |
– • – |
2013-06-14 |
4 |
S |
$46.06 |
$6,080,567 |
D/D |
(132,000) |
3,296,660 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
